Loading the section
Closing prices for 09 October 2026
Next earnings report: 03 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Sotera Health Company trades on Nasdaq under the ticker SHC. The company belongs to the Health care sector. The trading history on this page starts on 20 November 2020.
Over the past 52 weeks SHC has traded between 13.09 $ and 19.85 $. As of 09 October 2026 the price stood 73.52 % of the way from the 52-week low to the high.
Over one year SHC shares rose 12.88 %; over six months they rose 17.58 %. Volatility over 90 days is 27.57 %. Dividends are not included: this is price change only, as of 09 October 2026.
SHC trades at a price-to-earnings ratio of 42.9, above the sector median of 24.8. Price to sales is 4.2, above the sector median of 3.9. Price to book is 8.1, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 18.00 | 18.24 | 17.68 | 18.06 | 2M |
| 08 October 2026 | 17.80 | 18.25 | 17.51 | 17.83 | 2M |
| 07 October 2026 | 18.13 | 18.69 | 17.87 | 17.90 | 2M |
| 06 October 2026 | 18.77 | 18.98 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Sotera Health Company (SHC) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 1.2bn $, net income was 77.9m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS, OH, 44147, US
Sotera Health Company reported revenue of 1.2B $ and net income of 118M $ over the last four quarters. Net margin is 9.91 %. Revenue changed by +7.44 % year over year. Earnings per share are 0.41 $. Market capitalisation is 5.1B $.
SHC has a return on equity of 18.92 %, above the sector median of −41.68 %. Return on assets is 3.64 %, above the sector median of −32.11 %.
| 8M |
| VMDViemed Healthcare, Inc. | 9.52 | +1.17 % | 2M |
| MGRXMangoceuticals, Inc. | 0.4220 | −2.31 % | 249,358 |
| BRTXBioRestorative Therapies, Inc. | 1.86 | −1.59 % | 100,407 |
| CCELCryo-Cell International, Inc. | 4.36 | +4.56 % | 56,385 |
| 18.19 |
| 18.25 |
| 2M |
| 05 October 2026 | 18.28 | 18.71 | 18.16 | 18.55 | 3M |
| 02 October 2026 | 17.99 | 18.47 | 17.99 | 18.22 | 2M |
| 01 October 2026 | 18.40 | 18.49 | 18.09 | 18.12 | 2M |
| 30 September 2026 | 18.68 | 18.76 | 18.39 | 18.49 | 2M |
| 29 September 2026 | 18.43 | 18.65 | 18.28 | 18.60 | 2M |
| 28 September 2026 | 18.28 | 18.55 | 18.21 | 18.45 | 1M |
| 25 September 2026 | 18.44 | 18.58 | 18.21 | 18.34 | 1M |
| 24 September 2026 | 18.24 | 18.63 | 18.23 | 18.45 | 1M |
| 23 September 2026 | 18.68 | 18.82 | 18.17 | 18.29 | 2M |
| 22 September 2026 | 18.79 | 18.95 | 18.62 | 18.69 | 2M |
| 21 September 2026 | 18.81 | 18.94 | 18.52 | 18.70 | 2M |
| 18 September 2026 | 18.94 | 19.01 | 18.66 | 18.73 | 6M |
| 17 September 2026 | 19.64 | 19.64 | 18.94 | 18.95 | 2M |
| 16 September 2026 | 19.13 | 19.63 | 19.11 | 19.33 | 3M |
| 15 September 2026 | 18.58 | 18.99 | 18.56 | 18.98 | 2M |
| 14 September 2026 | 18.47 | 18.64 | 18.38 | 18.52 | 2M |